The CMGs offer information on the diagnosis and management of a range of conditions that present with varying frequency in primary and first contact care.
Herpes zoster ophthalmicus (HZO) is a potentially sight-threatening viral infection of the trigeminal nerve caused by a localised reactivation of the varicella zoster virus, also known as human herpesvirus-3. It can cause painful skin rashes on one side of the forehead and scalp, and ocular manifestations include conjunctivitis, keratitis and uveitis on the same side. Two-thirds of cases occur in the over 50s. This Clinical Management Guideline outlines the aetiology, signs and symptoms and evidence-based recommendations for diagnosing and managing HZO. It highlights the need for emergency GP treatment and potential urgent hospital eye service referral, while outlining options for non-pharmacological management and pharmacological treatment of mild cases.
Login to read further information on the diagnosis and management of herpes zoster ophthalmicus.
Sign in to continue
Want to read the rest of this page?
If you are a member, login to view this page. If you are not a member, simply register to gain free access to the rest of this content.
Herpes Zoster Ophthalmicus (HZO) - 14 August 2025 The aetiology section has been amended to include data on rates of recurrent herpes zoster ophthalmicus (HZO) and further information on eligibility for herpes zoster vaccination in the UK. The symptoms section has been updated to include possible prodromal symptoms and additional ocular symptoms which may occur in the acute phase of disease. The signs section has been amended to provide further information on the appearance of pseudodentrites, additional signs associated with disciform lesions and factors which increase the risk of recurrent HZO.
Download your member app to access essential clinical information; join your new online member community; easily share patient resources; browse optometry jobs; and much more!